HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antiprostaglandin synthetase activity of nonsteroidal anti-inflammatory drugs and gastrointestinal micro-bleeding: a comparison of flurbiprofen with benoxaprofen.

Abstract
By using 51Cr-labelled erythrocytes and 141Ce-labelled microspheres to correct for daily variations in faecal output, gastrointestinal microbleeding was measured in hospital patients with rheumatoid arthritis before and after administration of 2 propionic acid derivatives. These were flurbiprofen and benoxaprofen, respectively a potent and a weak prostaglandin synthetase inhibitor. Increased faecal blood loss occurred consistently with flurbiprofen and not with benoxaprofen. Our results provide indirect evidence for the cytoprotective effect of prostaglandins on the gastrointestinal mucosa in man. The quantitative correlation between faecal occult blood loss as measured by the above techniques and the Haemoccult slide test is also discussed.
AuthorsA C Yeung Laiwah, T E Hilditch, P W Horton, J A Hunter
JournalAnnals of the rheumatic diseases (Ann Rheum Dis) Vol. 40 Issue 5 Pg. 455-61 (Oct 1981) ISSN: 0003-4967 [Print] England
PMID6796008 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Benzoxazoles
  • Cyclooxygenase Inhibitors
  • Propionates
  • benoxaprofen
  • Flurbiprofen
Topics
  • Aged
  • Anti-Inflammatory Agents (adverse effects)
  • Arthritis, Rheumatoid (drug therapy)
  • Benzoxazoles (adverse effects)
  • Cyclooxygenase Inhibitors
  • Feces
  • Female
  • Flurbiprofen (adverse effects)
  • Gastrointestinal Hemorrhage (chemically induced)
  • Humans
  • Male
  • Middle Aged
  • Occult Blood
  • Propionates (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: